Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,518.00
(
-0.01%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
98.66
(
1.93%
)
Bitcoin
71,002.00
(
0.14%
)
News Focus
News Focus
Post# of 12660
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: nmstav post# 4219

Saturday, 06/09/2007 11:41:29 PM

Saturday, June 09, 2007 11:41:29 PM

Post# of 12660
>Dr. Urdal said the issues are minor and David would never lie.<

This statement came from a serious poster?

>Dendreon is producing Provenge for the 9902b trial out of NJ, something the FDA would never allow if it was a serious problem.<

According to whom?

>The FDA said the only barrier to approval was additional survival data, not anything associated with manufacturing.<

Wrong, as can immediately be verified by perusing the May 9 CC transcript.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today